Jubilant Pharmova Reports ₹685 Million Revenue and ₹76 Million Net Profit for Q2 September 2026
The company's unaudited standalone results for the quarter and half-year ended September 30, 2026, were approved and reviewed by independent auditors as per SEBI regulations.
Jubilant Pharmova Limited announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company reported total revenue from operations of ₹685 million for Q2 and ₹1,366 million for the half year, with a net profit of ₹76 million for the quarter. The results were reviewed by Walker Chandiok & Co LLP and comply with Indian Accounting Standards.
Jubilant Pharmova Limited
Financial Results
Jubilant Pharmova Limited announced its unaudited standalone and consolidated financial results for the quarter and half year ending September 30, 2026, reporting ₹685 million in revenue and ₹76 million in net profit for the quarter.
The Board of Directors approved the unaudited financial results at their meeting on November 13, 2026, for the quarter and half-year ended September 30, 2026.
For the quarter ended September 30, 2026, revenue from operations stood at ₹685 million, while the total revenue including other income was ₹694 million.
Profit before tax was ₹76 million for the quarter. After accounting for tax expenses, the net profit from continuing operations was ₹76 million.
For the half year ended September 30, 2026, revenue from operations reached ₹1,366 million with corresponding improvements in profits.
The standalone financial statements were prepared in accordance with Indian Accounting Standard 34 and reviewed by Walker Chandiok & Co LLP, who issued an unqualified review report confirming the statements comply with Listing Regulations requirements.
Highlights
- Q2 September 2026 revenue from operations: ₹685 million
- Q2 total income: ₹694 million
- Profit before tax for Q2: ₹76 million
- Net profit from continuing operations in Q2: ₹76 million
- Half year revenue from operations: ₹1,366 million
- Unaudited financial results approved on November 13, 2026, by the Board of Jubilant Pharmova Limited
Key Data Snapshot
What happened
- Jubilant Pharmova Limited approved its unaudited standalone and consolidated financial results for Q2 and H1 ended September 30, 2026.
- The total revenue from operations for Q2 was ₹685 million, and net profit after tax was ₹76 million.
- The results were considered and approved by the Board on November 13, 2026.
Key details
- The standalone financial results comply with Indian Accounting Standard 34 as mandated under the Companies Act, 2013.
- Walker Chandiok & Co LLP conducted a limited review of the unaudited financials and issued a report with no qualifications.
- The total income including other income in Q2 was ₹694 million.
- Net profit includes continuing operations; no significant discontinued operations were reported for the period.
Regulatory and governance context
- Results were submitted as per Regulation 33 and 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The company maintains compliance with applicable accounting standards and listing rules.
- Independent auditor's limited review report was provided in accordance with Standard on Review Engagements 2410.
Highlights
- Q2 September 2026 revenue from operations: ₹685 million
- Q2 total income: ₹694 million
- Profit before tax for Q2: ₹76 million
- Net profit from continuing operations in Q2: ₹76 million
- Half year revenue from operations: ₹1,366 million
- Unaudited financial results approved on November 13, 2026, by the Board of Jubilant Pharmova Limited
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 33
- Indian Accounting Standard 34 (Ind AS 34)
- Companies Act, 2013
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Kaynes Technology India Limited Reports Q2 FY2027 Un-audited Results and Enters Joint Venture to Produce TFT Modules
Kaynes Technology India Limited released its un-audited financial results for the quarter and half year ended September 30, 2026, and approved a joint venture with Toyokawa Techno Private Limited to produce Thin-Film Transistor Display Modules in India, while proposing voluntary strike-off of a subsidiary.
Read Full StoryITI Limited Reports ₹49,528 Lakh Revenue and ₹6,368 Lakh Consolidated Loss Before Tax for Half Year Ending September 2026
ITI Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended 30th September 2026, revealing total consolidated revenue of ₹49,528 lakh for the quarter and a consolidated loss before tax of ₹6,368 lakh for the half-year period.
Read Full StoryZetwerk Manufacturing Businesses Limited Reports Q2 FY2027 Loss with Rs. 886.06 Million Receivables Dispute, Appoints New Company Secretary
Zetwerk Manufacturing Businesses Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, reporting a loss before tax of Rs. 1,193.17 million for the quarter. The company highlighted ongoing litigation over receivables totaling Rs. 886.06 million, alongside key administrative updates.
Read Full Story